Displaying 69 London Biotech companies
 Filter
City
Country
Stage
Business Model
Industry
company score funding investors employees industries biz model city contact
CN BioJUST ADDED HIRING

Provider of single and multi-organ microphysiological systems.

75
$21M · Series B CN Innovations 101 to 250 Health Tech, Biotech London, UK •••••••••••@cn-bio.com
Causaly

Biomedical research discovery tool.

64
$60M · Series B ICONIQ Growth, Index Ventures, Pentech Ventures 51 to 100 Health Tech, AI, Biotech, Pharma B2B, SaaS London, UK •••••••••••@causaly.com
Apollo Therapeutics

Portfolio of pharmaceutical research and discovery.

64
$33M · Series C Patient Square Capital, Rock Springs Capital, M&G Investments 1 to 10 Biotech, Pharma London, UK •••••••••••@apollotherapeutics.com
Beacon Therapeutics

Oophthalmic gene therapy company to treat blinding retinal illnesses.

64
$120M · Series A Syncona Partners LLP 1 to 10 Health Tech, Biotech London, UK •••••••••••@beacontx.com
MIP DiscoveryJUST ADDED

Developer of non-biological affinity reagents to accelerate the production of cell and gene therapies.

64
$8M · Series A Mercia Asset Management 11 to 50 Health Tech, Biotech London, UK •••••••••••@mipdiscovery.com
Baseimmune

AI vaccine algorithm developer.

64
$11M · Series A Hoxton Ventures, Merck Global Health Innovation Fund, Cherry Ventures 1 to 10 AI, Biotech B2B, SaaS London, UK •••••••••••@baseimmune.co.uk
Complement Therapeutics

Preclinical stage treatment for geographic atrophy.

59
$78M · Series A Forbion Capital Partners, Gimv 1 to 10 Biotech London, UK •••••••••••@complementtx.com
FA Bio

Discovery and development platform of superior microbial bioproducts.

59
$6M · Series A Pymwymic, Clean Growth Fund 1 to 10 Biotech London, UK •••••••••••@fungialert.com
IMU Biosciences

AI platform to map the human immune system.

59
$14M · Series A Life Extension Ventures, Molten Ventures 11 to 50 Health Tech, Biotech London, UK •••••••••••@imubiosciences.com
SparxellJUST ADDED HIRING

Developer of sustainable plant-based pigments.

59
$3M · Seed PDS Ventures, Circular Innovation Fund, L'Oreal 1 to 10 Biotech, Manufacturing B2C London, UK •••••••••••@sparxell.com
Mytos

Fully-automated cell manufacturing.

59
$19M · Series A Buckley Ventures, Wing Venture Capital, IQ Capital Partners 11 to 50 Biotech, Machine Learning B2B London, UK •••••••••••@mytos.bio
Hexigone InhibitorsJUST ADDED HIRING

Sustainable corrosion inhibitors manufacturer.

59
$1M · Seed Oxford Innovation Finance, Waterspring Ventures, Development Bank of Wales 1 to 10 Biotech, Manufacturing B2B London, UK •••••••••••@hexigone.com
Stanhope AIJUST ADDED HIRING

Neuroscience-driven AI platform.

59
$2M · Seed Rockmount Capital, UCL Technology Fund, Moonfire Ventures 11 to 50 AI, Biotech B2B, SaaS London, UK •••••••••••@stanhopeai.com
Quell Therapeutics

Quell Therapeutics is a cell therapy company

54
$45M · Series A AlbionVC, Point72 Ventures 101 to 250 Health Tech, Edtech, Biotech, Manufacturing B2B London, UK •••••••••••@quell-tx.com
Lindus Health

Clinical trials platform.

54
$18M · Series A Valar Ventures, Seedcamp, Atomico 11 to 50 Health Tech, Biotech B2B, SaaS London, UK •••••••••••@lindushealth.com
Charm Therapeutics

CHARM Therapeutics uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins.

54
$50M · Series A General Catalyst, Khosla Ventures 1 to 10 Health Tech, AI, Biotech, Data and Analytics B2B London, UK •••••••••••@charmtx.com
Laverock Therapeutics

Gene silencing platform for the creation of programmable, allogeneic cell therapies.

54
$16M · Seed Mercia Asset Management, Calculus Capital, UK Innovation & Science Seed Fund 1 to 10 Health Tech, Biotech London, UK •••••••••••@laverocktx.com
Genomes

User-owned genomics database platform.

54
$20M · Series A GEM Digital 1 to 10 Health Tech, Biotech B2C London, UK •••••••••••@genomes.io
Flarin

Patent-protected anti-inflammatory painkiller.

54
$6M · Series A ITV AdVentures 1 to 10 Biotech, Pharma B2C London, UK •••••••••••@flarin.co.uk
Umedeor

Platform to automate the clinical studies process.

54
$12M · Series A Playfair, Delin Ventures, 11.2 Capital 11 to 50 Health Tech, Biotech B2B London, UK •••••••••••@umed.io
Hypervision Surgical

Precision software for eye surgery.

54
$8M · Seed Redalpine 1 to 10 Health Tech, Biotech London, UK •••••••••••@hypervisionsurgical.com
Tropic Biosciences

Tropic Biosciences is a pioneering leader in the development of novel high-performing commercial tropical crop varieties and traits.

54
$28M · Series B Future Planet Capital 11 to 50 Agritech, Biotech, Deep Tech, Manufacturing B2B London, UK •••••••••••@tropicbioscience.com
ReViral

ReViral is a biotechnology company that develops and offers antiviral therapies for patients.

54
$44M · Series C Novo A/S, Andera Partners 11 to 50 Health Tech, Biotech, Pharma B2B London, UK •••••••••••@reviral.co.uk
LabGenius

LabGenius is a biopharmaceutical company developing protein therapeutics using a machine learning-driven evolution engine.

54
$25M Kindred Capital, Atomico 51 to 100 Health Tech, AI, Biotech, Deep Tech, Machine Learning, Robotics, Manufacturing B2B London, UK •••••••••••@labgeni.us
Ori Biotech

Ori Biotech is a developer of a manufacturing platform used to help patients get access to lifesaving treatments.

54
$30M · Series A Kindred Capital, Octopus Ventures, Amadeus Capital 1 to 10 Health Tech, Biotech, Manufacturing B2B London, UK •••••••••••@oribiotech.com
Achilles Therapeutics

Immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer.

50
$17M · Seed AlbionVC, Boxer Capital, Syncona Partners LLP 101 to 250 Health Tech, Biotech B2B London, UK •••••••••••@achillestx.com
Daye

Daye is a gynecological health company that creates products and services for vaginal treatment.

50
$5M · Seed Index Ventures, Khosla Ventures, Kindred Capital 11 to 50 Health Tech, Biotech, Manufacturing, Ecommerce, Cannabis B2C London, UK •••••••••••@yourdaye.com
Kuano

Quantum simulation platform for drug discovery.

50
$2M · Seed Ascension Ventures, ACF Investors 1 to 10 Health Tech, Biotech B2B, SaaS London, UK •••••••••••@kuano.ai
Myricx Pharma

Myricx Pharma is a drug discovery company focused on developing small molecule inhibitors.

50
$6M · Seed Sofinnova Partners 1 to 10 Health Tech, Biotech, Deep Tech, Pharma B2B London, UK •••••••••••@myricxpharma.com
Opencell

OpenCell builds biotech labs in shipping containers with the aim of making biotechnology accessible and affordable.

50
$8M Seventure Partners 1 to 10 Fintech, Biotech, Proptech & Real Estate, Manufacturing B2B, SaaS London, UK •••••••••••@opencell.bio
Pathfinder Medical

Pathfinder is developing a novel catheter based system that provides a better way for patients to receive haemodialysis for kidney failure.

50
$11M · Series A Business Growth Fund, Deepbridge Capital, Parkwalk Advisors 1 to 10 Health Tech, Biotech, Manufacturing B2B London, UK •••••••••••@pathfindermed.com
Pear Bio

Cancer treatment predictor software.

50
$14M · Series A Hoxton Ventures, Octopus Ventures, Fly Ventures 11 to 50 Health Tech, Biotech, Pharma B2B London, UK •••••••••••@pearbio.com
Sixfold Bioscience

Sixfold Bioscience develops and researches on biotechnology advances for RNA therapies.

50
$10M Y Combinator, Pi Campus 11 to 50 Health Tech, Biotech, Robotics, Manufacturing, Business Intelligence B2B London, UK •••••••••••@sixfold.bio
Basecamp Research

Protein discovery research and manufacturing.

50
$19M · Series A SYSTEMIQ 11 to 50 Biotech, Deep Tech London, UK •••••••••••@basecamp-research.com
Multiomic Health

Precision therapeutics discovery platform.

50
$6M · Seed Hoxton Ventures 11 to 50 Biotech B2B London, UK •••••••••••@multiomic.uk
Bea Fertility

At-home fertility treatment.

50
$3M · Seed Octopus Ventures, Calm/Storm Ventures, QVentures 1 to 10 Health Tech, Biotech B2C London, UK •••••••••••@beafertility.com
ImmuONE

3D human lung model developer.

50
$2M · Seed Pioneer Group, Mercia Asset Management, Midlands Engine Investment Fund 11 to 50 Biotech, Deep Tech London, UK •••••••••••@immuone.com
Sable bio

AI-powered drug testing platform.

50
$1M · Pre Seed Seedcamp, Episode 1 1 to 10 AI, Biotech London, UK •••••••••••@sablebio.com
Bastion Therapeutics

Developer of novel Treg therapies to treat inflammatory disorders.

43
$840k · Pre Seed Deep Science Ventures, Wren Capital 1 to10 Health Tech, Biotech B2C London, UK •••••••••••@bastion-tx.com
Puraffinity

Puraffinity develops precision materials to target chemicals, with an initial focus on PFAS in water

43
$3M · Seed Kindred Capital, Verve Ventures 11 to 50 Climate Tech & Green Tech, Health Tech, Biotech, Deep Tech, Energy & Nuclear, Manufacturing B2B London, UK •••••••••••@puraffinity.com
Arborea

Arborea is industrialising photosynthesis to expand the world’s food supply

43
$4M · Seed Business Growth Fund 1 to 10 Climate Tech & Green Tech, Foodtech, Biotech, Manufacturing B2B London, UK •••••••••••@arborea.io
BioCorteX

Computer simulation to understand drug-bacteria interactions.

43
$5M · Seed Hoxton Ventures, Sofinnova Partners 1 to 10 Biotech London, UK •••••••••••@biocortex.co.uk
Hoxton Farms

Based in London, UK, Hoxton Farms is growing cultivated fat as an ingredient for the meat alternatives industry.

43
$3M · Seed BACKED VC, CPT Capital 11 to 50 Foodtech, Biotech, Manufacturing B2B London, UK •••••••••••@hoxtonfarms.com
Quaisr

Digital-twin simulator.

43
$3M · Pre Seed Crane Venture Partners 1 to 10 Biotech, Supply Chain & Logistics B2B London, UK •••••••••••@quaisr.io
Foodsteps

Foodsteps is a london-based startup that has developed a platform to help the food sector reduce its carbon footprint.

43
$4M Octopus Ventures, Ascension Ventures, Metaplanet Holdings 11 to 50 Climate Tech & Green Tech, Health Tech, Agritech, Foodtech, Biotech, Deep Tech, Energy & Nuclear, Business Intelligence B2B, SaaS London, UK •••••••••••@foodsteps.earth
FabricNano

Cell-free chemical manufacturer to produce bio-based alternatives

43
$3M · Seed Hoxton Ventures, Atomico, BACKED VC 11 to 50 Biotech B2B London, UK •••••••••••@fabricnano.com
NK:IO

Immunotherapy for the treatment of cancer.

43
$1M · Seed Cancer Research Horizons, UK Innovation & Science Seed Fund 11 to 50 Biotech, Pharma B2C London, UK •••••••••••@nk-io.com
Nature Metrics

Developer of cutting-edge DNA techniques to monitor biodiversity.

43
$3M · Seed SYSTEMIQ, BNP Paribas, Green Angel Ventures 11 to 50 Biotech London, UK •••••••••••@naturemetrics.co.uk
Epsilogen

Immuno-oncology company treats cancer with antibodies.

43
$2M · Series A AlbionVC, Novartis Venture Fund, Epidarex Capital 11 to 50 Health Tech, Biotech, Deep Tech, Pharma, Manufacturing, Genetics B2B London, UK •••••••••••@epsilogen.com
Epoch Biodesign

Epoch develops natural solutions to unnatural problems. First up: enzymes that transform plastics into circular chemicals.

43
$3M · Pre Seed Lowercarbon Capital, Ascension Ventures, BoxGroup 11 to 50 Biotech, Manufacturing B2B London, UK •••••••••••@epochbiodesign.com
Peptone

We are a translational biophysics company focusing on the discovery of novel therapeutics against intrinsically disordered proteins.

43
$2M Hoxton Ventures, Bessemer Venture Partners 11 to 50 Health Tech, Biotech, Pharma, Manufacturing B2B London, UK •••••••••••@peptone.io
Better Dairy

Building the future of food, starting with dairy.

43
$2M · Seed Entrepreneur First, Vorwerk Ventures, Redalpine 1 to 10 Agritech, Foodtech, Biotech, Manufacturing B2B, B2C London, UK •••••••••••@betterdairy.co.uk
Enterprise Therapeutics

Developer of drugs to treat respiratory diseases.

43
$2M · Series A Versant Ventures, Forbion Capital Partners, Imperial Innovations 11 to 50 Health Tech, Biotech London, UK •••••••••••@enterprisetherapeutics.com
Exogene

Exogene is a biotechnology company accelerating target & TCR discovery for cancer cell therapies using AI-enabled TCR-antigen screening.

39
$104k · Pre Seed Atomico, Entrepreneur First 1 to 10 Health Tech, AI, Biotech, Deep Tech, Pharma, Data and Analytics B2B London, UK •••••••••••@exogene.co.uk
Nuntius Therapeutics

Nuntius Therapeutics is pioneering a new class of targeted RNA, DNA and CRISPR therapies.

39
$125k · Pre Seed Y Combinator 1 to 10 Health Tech, Biotech, Deep Tech B2B London, UK •••••••••••@nuntiustx.com
Sequential Skin

Sequential Skin is improving human health with the world's first skin microbiome test for consumers and companies.

39
$500k · Pre Seed Metaplanet Holdings 11 to 50 Health Tech, Fashion, Biotech B2B London, UK •••••••••••@sequentialskin.com
Concert Bio

Concert Bio helps businesses create optimal microbial communities.

39
$1M · Pre Seed Nucleus Capital 1 to 10 Agritech, Biotech, Business Intelligence B2B, SaaS London, UK •••••••••••@concert.bio
Actimed Therapeutics

Developer of innovative treatment for muscle wasting disorders.

39
$1M · Seed Mankind Pharma 1 to 10 Biotech, Pharma London, UK •••••••••••@actimedtherapeutics.com
Neucruit

Neucruit is transforming the efficiency, transparency and diversity of clinical trials

39
$100k · Pre Seed Atomico, Nina Capital 11 to 50 Health Tech, Biotech, Hiring and Recruitement, Data and Analytics, Community & Lifestyle, Business Intelligence B2B, SaaS London, UK •••••••••••@neucruit.com
Bluezone Insurance

Bluezone Insurance offers personalized, same-day life cover for people with chronic conditions, like type 2 diabetes and heart diseases.

39
$1M · Seed Insurtech Gateway, Portfolio Ventures 1 to 10 Health Tech, Fintech, Biotech, Deep Tech, Insuretech B2C London, UK •••••••••••@bluezoneinsurance.co.uk
Lifebit

Biomedical CloudOS data platform.

39
$120k · Seed Eurazeo, Connect Ventures, Techstars 51 to 100 Health Tech, Biotech, Data and Analytics, Business Intelligence B2B, SaaS London, UK •••••••••••@lifebit.ai
Digistain

Digistain uses infrared scanning to determine which breast cancer patients are fit for chemotherapy.

39
$125k · Pre Seed Y Combinator 1 to 10 Health Tech, Hardware, Biotech, Manufacturing B2B London, UK •••••••••••@digistain.co.uk
Syrona Health

Syrona Health is a personalised digital health platform for Chronic Gynaecological/Uterine Conditions like Endometriosis, PCOS etc.

39
$253k · Seed Y Combinator, Katapult Accelerator 1 to 10 Health Tech, Biotech, Deep Tech, Femtech, Ecommerce, ElderTech, Fertility B2B London, UK •••••••••••@syronahealth.com
Twig bio

AI-powered bioengineering platform to develop eco-friendly substitutes to every day materials.

39
$610k · Seed Seedcamp, Project A Ventures, Creative UK 1 to 10 Biotech, Machine Learning London, UK •••••••••••@twig.bio
LiliumX

LiliumX discovers new bispecific antibodies against cancer by utilizing a protein technology platform to facilitate the scalable discovery.

39
$125k · Pre Seed Hoxton Ventures, Y Combinator 1 to 10 Health Tech, Biotech B2B, SaaS London, UK •••••••••••@liliumx.com
Shellworks

Shellworks is a biotech startup on a mission to make plastic waste a thing of the past.

39
$820k · Pre Seed Local Globe, Atomico, Ascension Ventures 1 to 10 Climate Tech & Green Tech, Biotech, Energy & Nuclear, Manufacturing, Supply Chain & Logistics B2B London, UK •••••••••••@theshellworks.com
Gardin

Gardin develops optical phenotyping technology and analytics to optimise food production.

39
$1M · Pre Seed Seedcamp, Molten Ventures, MMC Ventures 11 to 50 Agritech, Foodtech, Biotech, Data and Analytics B2B, SaaS London, UK •••••••••••@gardin.co.uk
Clustermarket

One lab management platform that brings people, equipment and data together - no matter where they are.

39
$1M Forward Partners 11 to 50 Health Tech, Biotech, Deep Tech B2B, SaaS London, UK •••••••••••@clustermarket.com
Emm

Emm is developing the next generation of bio-wearables for better healthcare

39
$1M Innovate UK 1 to 10 Biotech London, UK •••••••••••@emm.co